PIA
ABBV icon

Piedmont Investment Advisors’s AbbVie ABBV Stock Holding History

Piedmont Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-242,484
Closed -$18.5M – 5
2020
Q1 		$18.5M Buy
242,484
+22,844
+10% +$1.95M 0.73% 20
2019
Q4 		$19.4M Buy
219,640
+5,814
+3% +$483K 0.67% 22
2019
Q3 		$16.2M Buy
213,826
+7,183
+3% +$492K 0.63% 26
2019
Q2 		$15M Sell
206,643
-3,393
-2% -$267K 0.6% 23
2019
Q1 		$16.9M Buy
210,036
+58,042
+38% +$4.75M 0.69% 24
2018
Q4 		$14M Sell
151,994
-43,639
-22% -$3.84M 0.67% 27
2018
Q3 		$18.5M Buy
195,633
+57,417
+42% +$5.44M 0.78% 20
2018
Q2 		$12.8M Sell
138,216
-167,284
-55% -$16.3M 0.62% 29
2018
Q1 		$28.9M Sell
305,500
-58,539
-16% -$6.43M 0.77% 26
2017
Q4 		$35.2M Sell
364,039
-20,944
-5% -$1.97M 0.71% 35
2017
Q3 		$34.2M Sell
384,983
-32,105
-8% -$2.44M 0.73% 36
2017
Q2 		$30.2M Sell
417,088
-31,210
-7% -$2.1M 0.67% 37
2017
Q1 		$29.2M Buy
448,298
+4,763
+1% +$299K 0.6% 42
2016
Q4 		$27.8M Buy
443,535
+10,620
+2% +$648K 0.57% 53
2016
Q3 		$27.3M Buy
432,915
+65,120
+18% +$4.22M 0.59% 51
2016
Q2 		$22.8M Sell
367,795
-3,410
-0.9% -$208K 0.47% 62
2016
Q1 		$21.2M Buy
371,205
+5,700
+2% +$318K 0.45% 64
2015
Q4 		$21.7M Buy
365,505
+3,230
+0.9% +$186K 0.46% 59
2015
Q3 		$19.7M Sell
362,275
-17,660
-5% -$1.15M 0.45% 63
2015
Q2 		$25.5M Buy
379,935
+303,723
+399% +$19.8M 0.54% 56
2015
Q1 		$4.46M Sell
76,212
-25,020
-25% -$1.51M 0.27% 69
2014
Q4 		$6.62M Sell
101,232
-7,678
-7% -$484K 0.4% 48
2014
Q3 		$6.29M Buy
108,910
+47,730
+78% +$2.65M 0.33% 50
2014
Q2 		$3.45M Sell
61,180
-210
-0.3% -$11K 0.18% 88
2014
Q1 		$3.16M Sell
61,390
-1,700
-3% -$85.9K 0.17% 83
2013
Q4 		$3.33M Sell
63,090
-8,040
-11% -$395K 0.18% 76
2013
Q3 		$3.18M Buy
71,130
+14,400
+25% +$638K 0.17% 77
2013
Q2 		$2.35M Buy
+56,730
New +$2.48M 0.11% 115

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Piedmont Investment Advisors's ABBV Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of AbbVie (ABBV) in Q2 2020, closing a stake of 242,484 shares — an estimated $18.5M sold.

Piedmont Investment Advisors first reported a position in ABBV in Q2 2013 and held it in 28 quarters. The position peaked at $35.2M in Q4 2017. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining AbbVie position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 242,484 AbbVie shares in Q2 2020, an estimated $18.5M.
  • Piedmont Investment Advisors first reported a position in AbbVie in Q2 2013 and held it in 28 quarters.
  • Piedmont Investment Advisors's AbbVie position peaked at $35.2M in Q4 2017.
  • 2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.